The financial machinations behind Moderna are gruesome enough, but when you read how they affected the medical science and testing of Moderna’s vaccine you wouldn’t get it until they hold a gun to your head. Even then you might be “hesitant.” From Whitney Webb at unlimitedhangout.com:
COVID-19 erased the regulatory and trial-related hurdles that Moderna could never surmount before. Yet, how did Moderna know that COVID-19 would create those conditions months before anyone else, and why did they later claim that their vaccine being tested in NIH trials was different than their commercial candidate
In late 2019, the biopharmaceutical company Moderna was facing a series of challenges that not only threatened its ability to ever take a product to market, and thus turn a profit, but its very existence as a company. There were multiple warning signs that Moderna was essentially another Theranos-style fraud, with many of these signs growing in frequency and severity as the decade drew to a close. Part I of this three-part series explored the disastrous circumstances in which Moderna found itself at that time, with the company’s salvation hinging on the hope of a divine miracle, a “Hail Mary” save of sorts, as stated by one former Moderna employee.
While the COVID-19 crisis that emerged in the first part of 2020 can hardly be described as an act of benevolent divine intervention for most, it certainly can be seen that way from Moderna’s perspective. Key issues for the company, including seemingly insurmountable regulatory hurdles and its inability to advance beyond animal trials with its most promising—and profitable—products, were conveniently wiped away, and not a moment too soon. Since January 2020, the value of Moderna’s stock—which had embarked on a steady decline since its IPO—grew from $18.89 per share to its current value of $339.57 per share, thanks to the success of its COVID-19 vaccine.
Yet, how exactly was Moderna’s “Hail Mary” moment realized, and what were the forces and events that ensured it would make it through the FDA’s emergency use authorization (EUA) process? In examining that question, it becomes quickly apparent that Moderna’s journey of saving grace involved much more than just cutting corners in animal and human trials and federal regulations. Indeed, if we are to believe Moderna executives, it involved supplying formulations for some trial studies that were not the same as their COVID-19 vaccine commercial candidate, despite the data resulting from the former being used to sell Moderna’s vaccine to the public and federal health authorities. Such data was also selectively released at times to align with preplanned stock trades by Moderna executives, turning many of Moderna’s highest-ranking employees into millionaires, and even billionaires, while the COVID-19 crisis meant economic calamity for most Americans.
Not only that, but—as Part II of this three-part series will show, Moderna and a handful of its collaborators at the National Institutes of Health (NIH) seemed to know that Moderna’s miracle had arrived—well before anyone else knew or could have known. Was it really a coincidental mix of “foresight” and “serendipity” that led Moderna and the NIH to plan to develop a COVID-19 vaccine days before the viral sequence was even published and months before a vaccine was even considered necessary for a still unknown disease? If so, why would Moderna—a company clearly on the brink—throw everything into and gamble the entire company on a vaccine project that had no demonstrated need at the time?
Everyone who receives the Covid-19 vaccines is an unpaid guinea pig with very little chance of receiving damages should anything go wrong . . . and things are indeed going wrong. From Joseph Mercola at lewrockwell.com (for the video mentioned in the story click the lewrockwell.com link):
In the featured video, which aired June 22, 2021, independent reporter Stew Peters plays an audio recording1 made by a young woman who suddenly developed Guillain-Barre syndrome after her Moderna injection. Her neurologist believes her condition is the direct result of the COVID shot.
While the neurologist filed an adverse event report with the U.S. Vaccine Adverse Events Reporting System (VAERS), the woman decided to report it to Moderna as well. The Moderna rep does not appear the least surprised by the injury, and appears to admit he’s received similar reports before.
Everyone Who Gets the Jab Is Part of the Safety Trial
During that call, the Moderna representative reads her the following disclaimer:
“The Moderna COVID-19 vaccine has not been approved or licensed by the Food and Drug Administration, but it has been authorized for emergency use by the FDA under an emergency use authorization to prevent coronavirus disease 2019, for use in individuals 18 years of age and older.
There is no FDA-approved vaccine to prevent COVID-19. The EUA for the Moderna COVID-19 vaccine is in effect for the duration of the COVID-19 EUA declaration, justifying emergency use of the product unless that declaration is terminated or the authorization is revoked sooner.”
The rep also points out that all clinical trial phases are still ongoing, and that long-term protective efficacy against COVID-19 is unknown. When the patient asks whether everyone who gets the COVID shot — even if they did not specifically sign up to be a trial participant — is in fact part of the clinical trial, he replies, with a chuckle, “pretty much, yeah.”
In a small town in British Columbia, the Moderna vaccine is proving more debilitating and deadly than Covid. From Dr. Charles B. Hoffe, with a hat tip to and an introduction by Francis Marion at theburningplatform.com:
This is from a small rural community to the north of me. There are only a few hundred people living in it so I would guess that the majority of the folks this physician is referring to are from local Indian reserves outside of town.
The Federal and Provincial governments put 1st Nations at the front of the cue for Covid vaccination. I said before it began that given our government’s history with Native people if I was them I would probably decline. I was called a conspiracy theorist. Now, not so much.
At this stage the province and our chief medical officer, Dr. Bonnie Henry, have not responded to Dr. Hoffe, at least not as far as I can tell.
Dr. Charles D. Hoffe, BSc, MB, BCh, LMCC
Lytton Medical Clinic
Lytton BC V0K 1Z0
5 April, 2021
Dr. Bonnie Henry,
British Columbia Provincial Health Officer
Ministry of Health
1515 Blanchard Street
Victoria, BC, V8W 3C9
Dear Dr. Henry,
The first dose of the Moderna vaccine has now been administered to some of my patients in the community of Lytton, BC. This began with the First Nations members of our community in mid-January, 2021. 900 doses have now been administered.
I have been quite alarmed at the high rate of serious side-effects from this novel treatment.
From this relatively small number of people vaccinated so far, we have had:
- Numerous allergic reactions, with two cases of anaphylaxis.
- One (presumed) vaccine induced sudden death, (in a 72 year old patient with COPD. This patient complained of being more short of breath continually after receiving the vaccine, and died very suddenly and unexpectedly on day 24, after the vaccine. He had no history of cardiovascular disease).
While you can’t say conclusively that this death was caused by the Moderna vaccine, it sure as hell isn’t an argument for taking that vaccine. From Samual Allegri at theepochtimes.com:
A 39-year-old healthy single mother from Utah died four days after taking a second dose of the Moderna COVID-19 vaccine on Feb. 1.
According to local news channel KUTV, her family said that Kassidi Kurill, who was a surgical technician for plastic surgeons, “had more energy” than most people around her and was a happy person with no known health problems.
“I didn’t really cry when my dad died. I cry a lot for her,” her father, Alfred Hawley, a former fighter pilot in the Air Force, told the outlet. “She was the one who promised to take care of me.”
“She was seemingly healthy as a horse,” Hawley told Fox News. “She had no known underlying conditions.”
Hawley said that Kurill started to have symptoms after receiving the shot, experiencing soreness at the shot location, then beginning to feel ill and complaining that she couldn’t urinate despite drinking plenty of fluids. She improved slightly the next day, but then her condition worsened; she said she had headaches, felt nauseated, and still couldn’t urinate.